{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:19:18Z","timestamp":1788380358045,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507405"],"award-info":[{"award-number":["2023YFC2507405"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016345","name":"Renmin Hospital of Wuhan University","doi-asserted-by":"publisher","award":["JCRCFZ-2022-01"],"award-info":[{"award-number":["JCRCFZ-2022-01"]}],"id":[{"id":"10.13039\/501100016345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.aohep.2026.102184","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T16:24:23Z","timestamp":1768494263000},"page":"102184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening and management for portal hypertension in hepatocellular carcinoma: A nationwide survey in China"],"prefix":"10.1016","volume":"31","author":[{"given":"Xueyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2620-7603","authenticated-orcid":false,"given":"Qingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaotong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.aohep.2026.102184_bib0001","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","article-title":"Systemic treatment of hepatocellular carcinoma: An EASL position paper","volume":"75","author":"Bruix","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102184_bib0002","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cld.2024.08.004","article-title":"Management of Chronic Liver Disease in Patients with Hepatocellular Carcinoma","volume":"29","author":"Henry","year":"2025","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.aohep.2026.102184_bib0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.dld.2018.07.014","article-title":"Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis","volume":"51","author":"Allaire","year":"2019","journal-title":"Digest and Liver Dis"},{"issue":"1","key":"10.1016\/j.aohep.2026.102184_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.27864","article-title":"Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation","volume":"62","author":"Faitot","year":"2015","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.aohep.2026.102184_bib0005","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.aohep.2026.102184_bib0006","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102184_bib0007","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 Renewing consensus in portal hypertension","volume":"76","author":"De Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102184_bib0008","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1148\/radiographics.22.5.g02se011053","article-title":"Three-dimensional Multi\u2013Detector Row CT Portal Venography in the Evaluation of Portosystemic Collateral Vessels in Liver Cirrhosis","volume":"22","author":"Kang","year":"2002","journal-title":"RadioGraphics"},{"issue":"2","key":"10.1016\/j.aohep.2026.102184_bib0009","doi-asserted-by":"crossref","first-page":"102059","DOI":"10.1016\/j.clinre.2022.102059","article-title":"Screening and management of portal hypertension in advanced hepatocellular carcinoma: A French practice survey","volume":"47","author":"Allaire","year":"2023","journal-title":"Clinics and Rese in Hepato and Gastroente"},{"issue":"3","key":"10.1016\/j.aohep.2026.102184_bib0010","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2022.11.019","article-title":"Treatment of portal hypertension in patients with HCC in the era of Baveno VII","volume":"78","author":"Thabut","year":"2023","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2026.102184_bib0011","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2023.05.017","article-title":"A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma","volume":"55","author":"Piscaglia","year":"2023","journal-title":"Diges and Liver Dise"},{"issue":"4","key":"10.1016\/j.aohep.2026.102184_bib0012","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2016.11.001","article-title":"Beta adrenergic blockade and decompensated cirrhosis","volume":"66","author":"Reiberger","year":"2017","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102184_bib0013","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s00270-013-0698-8","article-title":"Efficacy of TACE in TIPS Patients: Comparison of Treatment Response to Chemoembolization for Hepatocellular Carcinoma in Patients With and Without a Transjugular Intrahepatic Portosystemic Shunt","volume":"36","author":"Kuo","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"10.1016\/j.aohep.2026.102184_bib0014","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ueg2.12454","article-title":"Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: a systematic review","volume":"11","author":"Norero","year":"2023","journal-title":"United European Gastroenterol J"},{"issue":"8","key":"10.1016\/j.aohep.2026.102184_bib0016","doi-asserted-by":"crossref","first-page":"101790","DOI":"10.1016\/j.clinre.2021.101790","article-title":"TIPS for patients with early HCC: A bridge to liver transplantation","volume":"46","author":"Larrey","year":"2022","journal-title":"Clin and Res in Hepato and Gastroenterol"},{"issue":"43","key":"10.1016\/j.aohep.2026.102184_bib0015","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.3748\/wjg.v21.i43.12439","article-title":"Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension","volume":"21","author":"Qiu","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102184_bib0017","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12328-022-01605-9","article-title":"Two cases of rapid progression of esophageal varices after atezolizumab\u2013bevacizumab treatment for hepatocellular carcinoma","volume":"15","author":"Furusawa","year":"2022","journal-title":"Clin J Gastroenterol"},{"issue":"8","key":"10.1016\/j.aohep.2026.102184_bib0018","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jfma.2024.03.019","article-title":"Progression of portal hypertension after atezolizumab plus bevacizumab for hepatocellular carcinoma-report a case and literature review","volume":"123","author":"Lin","year":"2024","journal-title":"J Formo Med Associ"},{"issue":"12","key":"10.1016\/j.aohep.2026.102184_bib0019","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1111\/liv.15458","article-title":"A history of variceal bleeding is associated with further bleeding under atezolizumab\u2013bevacizumab in patients with HCC","volume":"42","author":"Larrey","year":"2022","journal-title":"Liver Int"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:51:29Z","timestamp":1788378689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268126000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1665268126000050"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102184","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening and management for portal hypertension in hepatocellular carcinoma: A nationwide survey in China","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C.","name":"copyright","label":"Copyright"}],"article-number":"102184"}}